Ensysce Biosciences Inc.

NASDAQ: ENSC · Real-Time Price · USD
2.08
0.02 (0.97%)
At close: Aug 15, 2025, 3:59 PM
2.09
0.64%
After-hours: Aug 15, 2025, 05:36 PM EDT

Ensysce Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-1.73M -1.95M -3.56M 661.77K -1.97M -3.12M -3.5M -2.69M -2.24M -2.19M -5.48M -9.86M -7.92M -950.92K -10.04M -17.2M -997.61K -911.69K
Depreciation & Amortization
n/a n/a n/a n/a 25.73K 1.17M 326.15K n/a n/a n/a n/a n/a n/a n/a -151 50.00 50.00 51.00
Stock-Based Compensation
156.92K 46.09K 30.15K 20.82K 26.55K 33.21K 628.94K 55.67K 77.42K 117.13K 216.68K 157.15K 295.58K 402.43K 16.74K 24.83K 36.37K 43.82K
Other Working Capital
n/a 822.46K 1.62M -3.56M 239.35K -220.52K -1.22M 740.32K -579.45K 1.35M 1.09M 1.19M 252.02K 301.41K -1.61M 1.83M -155.14K 56.02K
Other Non-Cash Items
-1.13M 9.28K 17.64K -2.34K -5.99K 18.25K 482.12K -9.62K -43.67K -364.06K -783.89K 3.55M 846.62K -3.85M 5.65M 577.34K 909.74K 448.11K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -476.71K n/a n/a n/a n/a n/a n/a n/a 2.38M 12.54M -365.33K -61.28K
Change in Working Capital
n/a 182.79K 2.75M -1.7M -388.39K -1.51M 742K 382.11K -902.99K -1.17M 2.75M -568.2K 2.34M 959.94K -1.78M 229.56K 284.47K -36.16K
Operating Cash Flow
-2.71M -1.71M -764.09K -1.02M -2.31M -3.41M -1.8M -2.26M -3.11M -3.61M -3.3M -6.71M -4.44M -3.44M -3.77M -3.82M -132.31K -517.15K
Capital Expenditures
n/a n/a n/a -4 n/a 3.00 -5 -4 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 4.5K n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 62.5K -62.5K
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 4.5K n/a n/a 4.5K n/a n/a n/a -62.5K
Investing Cash Flow
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 4.5K n/a n/a 4.5K n/a n/a 62.5K -62.5K
Debt Repayment
n/a -47.23K -96.27K -71.35K -51.23K -638.87K 1.61M -102.45K -584.86K -415.35K -1.14M 7.53M -265.81K n/a 8.98M 4.03M 50K 350K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a -290 -4.63K n/a n/a n/a n/a n/a n/a -715.58K n/a n/a n/a n/a
Other Financial Acitivies
1.87M -142.95K 1.88M 2.53M n/a -465.2K -139.91K n/a -253.84K -398.72K -700.45K -51.17K n/a -391.27K 207.03K -195.42K 7.8M 262.86K
Financial Cash Flow
1.87M 1.26M 112.58K 4.13M -51.23K 5.69M 1.46M -102.45K 5.52M 1.87M 1.94M 7.48M -265.81K -391.27K 9.19M 2.66M 7.85M 612.86K
Net Cash Flow
-840.92K -449.59K -651.51K 3.11M -2.36M 2.28M -340.78K -2.37M 2.41M -1.73M -1.36M 768.43K -4.71M -3.82M 5.42M -1.17M 7.72M 95.71K
Free Cash Flow
-2.71M -1.71M -764.09K -1.02M -2.31M -3.41M -1.8M -2.26M -3.11M -3.61M -3.3M -6.71M -4.44M -3.44M -3.77M -3.82M -132.31K -517.15K